Научная статья на тему 'The relationship between citation-based metrics and Twitter in the area of age related macular degeneration research: Altmetric and bibliometric study'

The relationship between citation-based metrics and Twitter in the area of age related macular degeneration research: Altmetric and bibliometric study Текст научной статьи по специальности «Клиническая медицина»

CC BY
37
14
i Надоели баннеры? Вы всегда можете отключить рекламу.
Ключевые слова
altmetric attention score / altmetric / bibliometric / age related macular degeneration / Twitter

Аннотация научной статьи по клинической медицине, автор научной работы — Sumeyra Koprubasi, Erkan Bulut, Ali Riza Cenk Celebi

Purpose: The aim of this research is to analyze the bibliometric and altmetric scores of highly cited articles in the area of age related macular degeneration (AMD) research and to assess the correlations between them. Material and methods: The data of publications in last decade were retrieved from the Web of Science Core Collection database using "age related macular degeneration" as a search term. The top 100 cited articles (T100) list was analyzed by author name, publication year, main topic, study type, journal name, journal impact factor (IF), H-index, total citation number (TCN), average citation per year (ACpY), Altmetric attention score (AAS), and number of tweets (NTs). VOSviewer software was utilized for visualization of bibliometric data. Results: We discovered 16.984 articles in the last decade. The median values for TCN and AAS were 221 (IQR 178–380.75) and 13 (IQR 4-37.75), respectively in T100 list. The majority of the highly cited articles in AMD research have mainly focused on AMD treatment (n=34), especially anti-vascular endothelial growth factor therapy. However, social attention was primarily on the stem cell therapy. While AAS and NTs did not have significant correlation with TCN, they did show a significant positive correlation with ACpY. AAS and NTs showed significant positive correlation with journal IF and H-index. Conclusion: Treatment for AMD is the most interested issue in the area. Stem cell therapies are popular on social media. The interest of social media is on articles that continue to be cited over the years rather than articles with high total citations.

i Надоели баннеры? Вы всегда можете отключить рекламу.
iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.
i Надоели баннеры? Вы всегда можете отключить рекламу.

Текст научной работы на тему «The relationship between citation-based metrics and Twitter in the area of age related macular degeneration research: Altmetric and bibliometric study»

JQYK) JOURNAL OF CLINICAL MEDICINE OF KAZAKHSTAN

Original Article

(E-ISSN 2313-1519)

DOI: https://doi.org/10.23950/jcmk/12502

The relationship between citation-based metrics and Twitter in the area of age related macular degeneration research: Altmetric and bibliometric study

Sumeyra Koprubasi1, Erkan Bulut2, Ali Riza Cenk Celebi3

'Department of Ophthalmology, Sancaktepe §ehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey department of Opticianry, Vocational School of Health Services, Istanbul Gelisim University, Istanbul, Turkey Department of Ophthalmology, Faculty of Medicine, Acibadem University, Istanbul, Turkey

Abstract

Purpose: The aim of this research is to analyze the bibliometric and altmetric scores of highly cited articles in the area of age related macular degeneration (AMD) research and to assess the correlations between them.

Material and methods: The data of publications in last decade were retrieved from the Web of Science Core Collection database using "age related macular degeneration" as a search term. The top 100 cited articles (T100) list was analyzed by author name, publication year, main topic, study type, journal name, journal impact factor (IF), H-index, total citation number (TCN), average citation per year (ACpY), Altmetric attention score (AAS), and number of tweets (NTs). VOSviewer software was utilized for visualization of bibliometric data.

Results: We discovered 16.984 articles in the last decade. The median values for TCN and AAS were 221 (IQR 178-380.75) and 13 (IQR 4-37.75), respectively in T100 list. The majority of the highly cited articles in AMD research have mainly focused on AMD treatment (n=34), especially antivascular endothelial growth factor therapy. However, social attention was primarily on the stem cell therapy. While AAS and NTs did not have significant correlation with TCN, they did show a significant positive correlation with ACpY. AAS and NTs showed significant positive correlation with journal IF and H-index.

Conclusion: Treatment for AMD is the most interested issue in the area. Stem cell therapies are popular on social media. The interest of social media is on articles that continue to be cited over the years rather than articles with high total citations.

Key words: altmetric attention score, altmetric, bibliometric, age related macular degeneration, Twitter

Received: 2022-07-03. Accepted: 2022-08-19

© ©

This work is licensed under a Creative Commons Attribution 4.0 International License

J Clin Med Kaz 2022; 19(5):12-22

Corresponding author: Sumeyra Koprubasi. E-mail: [email protected]; ORCID: 0000-0002-2968-9855

Introduction

Age related macular degeneration (AMD) is the main cause of blindness in persons over the age of 60 in developed countries [1]. The prevalence of AMD is 2% in people over the age of 50 and 25% in people over the age of 80 [2]. Early detection and follow-up of AMD, treatment planning, boosting public awareness, and enhancing communication between healthcare providers and patients are crucial.

Bibliometric analysis is a statistical tool for determining the worth and efficiency of a scientific article by counting the number of citations received since its publication [3]. Bibliometric analysis gives data on the

most scientifically effective journals, authors, countries, important topics and keywords, as well as number of citations [4]. Map knowledge domain is a technique for graphing and visualizing bibliometric information in addition to doing co-occurrence assessment and identifying hotspots. It provides researchers information about research topics, new trends, and developing new study aspects [5]. While citation-based analyses are beneficial for determining the quality of articles, they have considerable limitations. A certain period of time must have passed since its publication that limits the rapid evaluation of an article's quality.

Altmetric, which has been using the effect of

social media, has created a new score system for determining the impact of publications. Altmetric attention score (AAS) quantifies the impact value of articles shared, discussed, and viewed on Wikipedia, Mendeley, news, blogs, and social media platforms such as Twitter, Facebook, Pinterest [6-9].

By the beginning of 2021, the global number of daily active Twitter users reached 187 million, with an average of 500 million tweets every day [10]. Medical journals are also intending to boost the accessibility of their publications by posting them on their own Twitter accounts.

There have been no published research that investigate the relationships between altmetric analysis and bibliometric analysis including citation count, journal impact factor (IF), and H-index in the area of AMD research. The purpose of this study is to give bibliometric and altmetric summaries and visualizations of the AMD research. Additionally, we aimed to analyze the effect of Twitter on both metrics in terms of scientific information dissemination.

Material and methods Study design

This retrospective clinical research has a level of evidence of three or group B under Scottish Intercollegiate Guidelines Network (SIGN) [11].

Compliance with ethical standards

Each author confirms that the study was conducted in accordance with the Helsinki Declaration's Ethical Principles. There is no need for ethical approval for this investigation because it consists of existing publications related to AMD in the literature.

Data collection

The information was obtained from the Web of Science (WoS) Core Collection database (Philadelphia, Pennsylvania, United States) using "age related macular degeneration" as a search term (Date of access: April 3, 2021). The articles published between 2011 and 2021 years were selected. Full text articles were gathered and sorted according to the number of citations for each article [12]. All articles were thoroughly reviewed by each author and PubMed was used to obtain additional information about publications. The articles that were not relevant to AMD in the human health category were excluded. In the human health category, articles on the epidemiology, etiology, pathophysiology, histology, diagnosis, therapy, and prognosis of AMD were included. The articles were rated from top to lowest depending on the amount of citations, and the top-100 cited articles list (T100 list) was created with the agreement of all authors. The data was recorded into Microsoft Excel files and analyzed. The journals IF were registered based on the 2019 Clarivate Journal Citation Reports. The H-index and quartile (Q) scores of journals were determined using the 2020 Scimago Journal and Country Rank (SJCR). Study types and level of evidence were determined using SIGN [11]. All articles of T100 list were extensively evaluated and categorized by journal name, publication year, first author name, total citation number (TCN), average citation number per year (ACpY), study topic, study type, and level of evidence.

VOSviewer software version 1.6.16 was used to visualize the bibliometric statistics of T100 list (https://www.vosviewer. com). The data of top-100 cited articles was acquired from WoS in the "Full record and cited references" formats. A bibliometric coupling analysis was performed on all countries in the T100 list. Threshold value determined as 2 for co-occurrence keyword

Figure 1-Altmetric donuts: Each color on the altmetric donut symbolizes a distinct source of attention. The weight score for posts of each social media platform is displayed.

NEWS

BLOG

8

POLICY DOCUMENT

PATENT

WIKIPEDIA

►3 •3 •3

PEER REW1EV

-•0,5

»0,25

>0,25

► 0,25

► 0,25

■ 11646 1

analysis. The findings of country coupling and keyword cooccurrence analyses were visualized on maps.

The Altmetric.com website's "Altmetric it" tool was used to measure AAS of the T100 list. (https://www.altmetric.com/ products/free-tools/bookmarklet/) (Date of access: April 3, 2021). AAS was computed by the process with a methodology defined as weighted average of all the attention that each paper received. Each color on the altmetric donut symbolizes a distinct area of attention (Figure 1). Additionally, the number of tweets (NTs) associated with each article was recorded.

Statistical analysis

IBM SPSS for windows version 23.0 (Statistical Package for Social Sciences, Chicago, Illinois, USA) was performed for the statistical analysis. Median and interquartile range (IQRs) were used to describe continuous variables, while percentages were used to define categorical variables. For intragroup and intergroup comparisons, the Mann-Whitney U and Kruskal Wallis tests were utilized. Sperman or Pearson correlation coefficients were used to analyze linear relationship between numerical variables. The correlation coefficients were assessed as follows: less than 0.4, weak; 0.4-0.6, moderate; 0.6-0.8, strong; and 0.81-1.00, very strong association [13]. A univariate linear regression analysis was performed to measure beta coefficients. When P was less than 0.05, statistical significance was assumed.

Results

We discovered 16.984 articles between 2011 and 2021 years using the phrase "age related macular degeneration" in our WoS search. The first author, publication year, TCN, and ACpY, AAS, and NTs for each article are displayed in T100 list, which was generated by sorting the top-100 articles based on TCN (Table 1). Although we did not specify the language option, all articles in the T100 list were written in English.

TCN and AAS analysis

The median values for TCN and AAS were 221 (IQR 178-380.75) and 13 (IQR 4-37.75), respectively in T100 list. The article with the highest TCN was Martin DF et al's article entitled as "Ranibizumab and bevacizumab for neovascular age-related macular degeneration the CATT research group" and it

Table 1

Top-100 articles by metrics (T100 list)

Citation rank Title First author Year TCN ACpY AAS NTs

1 Ranibizumab and bevacizumab for neovascular age-related macular degeneration the CATT research group Martin D.F. 2011 1667 151.6 97 17

2 Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and metaanalysis Wong W.L. 2014 1302 162.8 204 15

3 Intravitreal aflibercept (vegf trap-eye) in wet age-related macular degeneration Heier J.S. 2012 1171 117.1 38 3

4 Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration Martin D. F. 2012 1090 109 49 15

5 Age-related macular degeneration Lim L.S. 2012 899 89.9 56 9

6 Embryonic stem cell trials for macular degeneration: a preliminary report Schwartz S.D. 2012 890 89 318 119

7 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis Flaxman S.R. 2017 659 131.8 614 81

8 Identifying medical diagnoses and treatable diseases by image-based deep learning Kermany D.S. 2018 622 155.5 371 175

9 Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies Schwartz S.D. 2015 613 87.57 423 92

10 Clinical classification of age-related macular degeneration Ferris F.L. 2013 570 63.33 74 0

11 Lutein plus zeaxanthin and omega-3 fatty acids for age-related macular degeneration the age-related eye disease study 2 (AREDS2) randomized clinical trial Chew E.Y. 2013 533 59.22 247 77

12 Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration Chakravarthy U. 2012 522 52.2 21 8

13 Seven new loci associated with age-related macular degeneration Fritsche L.G. 2013 514 57.11 89 28

14 Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON Rofagha S. 2013 512 56.89 8 2

15 Autologous induced stem-cell-derived retinal cells for macular degeneration Mandai M. 2017 507 101.4 793 247

16 A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants Fritsche L.G. 2016 495 82.5 195 57

17 The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited Anderson D.H. 2010 472 39.33 15 0

18 Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes Ting D.S.W. 2017 469 93.8 289 328

19 Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/bruch's membrane/choriocapillaris complex Bhutto I. 2012 463 46.3 4 1

20 Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration Jia Y. 2014 456 57 16 1

21 Alternative treatments to inhibit vegf in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial Chakravarthy U. 2013 440 48.89 115 34

22 Mechanisms of age-related macular degeneration Ambati J. 2012 429 42.9 28 7

23 Intravitreal aflibercept injection for neovascular age-related macular degeneration ninety-six-week results of the VIEW studies Schmidt-Erfurth U. 2014 425 53.13 14 0

24 Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration Chung S.E. 2011 381 34.64 3 0

25 DICER1 deficit induces ALU RNA toxicity in age-related macular degeneration Kaneko H. 2011 381 34.64 43 0

26 Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis Chakravarthy U. 2010 380 31.67 3 0

27 Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration Chen W. 2010 373 31.08 33 1

28 DICER1 loss and ALU RNA induce age-related macular degeneration via the NLRP3 inflammasome and MYD88 Tarallo V. 2012 348 34.8 23 15

29 Prevalence of age-related macular degeneration in the US population Klein R. 2011 321 29.18 22 0

30 Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials Grunwald J.E. 2014 311 38.88 4 0

31 Immunology of age-related macular degeneration Ambati J. 2013 307 34.11 15 8

32 Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) Neale B.M. 2010 307 25.58 18 0

33 Consequences of oxidative stress in age-related macular degeneration Jarrett S.G. 2012 275 27.5 11 2

34 Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration the comparison of age-related macular degeneration treatments trials Maguire M.G. 2016 268 44.67 952 28

35 The prevalence of age-related macular degeneration in Asians a systematic review and meta-analysis Kawasaki R. 2010 265 22.08 1 1

36 Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration Busbee B.G. 2013 263 29.22 7 0

37 Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study Holz F.G. 2011 263 23.91 9 0

38 Reticular pseudodrusen are subretinal drusenoid deposits Zweifel S.A. 2010 259 21.58 3 0

39 Regulation of angiogenesis and choroidal neovascularization by members of microrna-23 similar to 27 similar to 24 clusters Zhou Q. 2011 254 23.09 13 1

40 Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study Schmidt-Erfurth U. 2011 254 23.09 14 1

41 Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration Holz F.G. 2015 246 35.14 12 7

42 NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components Doyle S.L. 2012 243 24.3 12 7

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

43 Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Laude A. 2010 238 19.83 0 0

44 Spectral-domain optical coherence tomography angiography of choroidal neovascularization de Carlo T.E. 2015 232 33.14 13 5

45 Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Freund K.B. 2010 230 19.17 1 0

46 Age-related macular degeneration: genetics and biology coming together Fritsche L.G. 2014 226 28.25 31 2

47 HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration Singer M.A. 2012 226 22.6 16 2

48 Ranibizumab (lucentis) in neovascular age-related macular degeneration: evidence from clinical trials Mitchell P. 2010 224 18.67 7 1

49 Inflammation and its role in age-related macular degeneration Kauppinen A. 2016 223 37.17 7 4

50 Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy Koizumi H. 2011 223 20.27 0 0

51 Guidelines for the management of neovascular age-related macular degeneration by the european society of retina specialists (EURETINA) Schmidt-Erfurth U. 2014 219 27.38 124 21

52 Subretinal drusenoid deposits in non-neovascular age-related macular degeneration morphology, prevalence, topography, and biogenesis model Curcio C.A. 2013 218 24.22 13 0

53 A rare penetrant mutation in CFH confers high risk of age-related macular degeneration Raychaudhuri S. 2011 212 19.27 30 8

54 Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search Fang L. 2017 211 42.2 4 1

55 Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration Mullins R.E. 2011 203 18.45 0 0

56 Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy Kim S.W. 2011 199 18.09 3 0

57 Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to lucas treat-and-extend protocol Berg K. 2015 198 28.29 4 2

58 A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact Gupta O.P. 2010 197 16.42 1 0

59 Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD Mitter S.K. 2014 194 24.25 0 0

60 Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration Zweifel S.A. 2010 193 16.08 3 0

61 Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration Kuehlewein L. 2015 189 27 1 1

62 Rare variants in CFI. C3 and C9 are associated with high risk of advanced age-related macular degeneration Seddon J.M. 2013 189 21 23 8

63 Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression AREDS2 report no. 3 Chew E.Y. 2014 188 23.5 37 17

64 Anti-vascular endothelial growth factor for neovascular age-related macular degeneration Solomon S.D. 2014 188 23.5 14 5

65 The oil spill in ageing bruch membrane Curcio C.A. 2011 187 17 8 2

66 Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration Kaarniranta K. 2013 186 20.67 1 2

67 Molecular pathogenesis of retinal and choroidal vascular diseases Campochiaro P. A. 2015 182 26 7 1

68 Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD Avery R.L. 2014 182 22.75 14 5

69 The prevalence of age-related macular degeneration and associated risk factors Klein R. 2010 182 15.17 0 0

70 Geographic atrophy clinical features and potential therapeutic approaches Holz F.G. 2014 181 22.63 13 1

71 Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2 Abraham P. 2010 181 15.08 3 0

72 The estimated prevalence and incidence of late stage age related macular degeneration in the UK Owen C.G. 2012 180 18 24 2

73 Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration Zhang K. 2011 180 16.36 0 0

74 Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients Song W.K. 2015 179 25.57 111 69

75 The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD Datta S. 2017 178 35.6 3 0

76 Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration Ying G. 2013 178 19.78 10 1

77 Animal models of age related macular degeneration Pennesi M.E. 2012 178 17.8 6 0

78 Age-related macular degeneration Mitchell P. 2018 177 44.25 50 84

79 Common variants near FRK/COL10A1 and vegfa are associated with advanced age-related macular degeneration Yu Y. 2011 177 16.09 8 2

80 Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health Abdel A. 2013 176 19.56 189 14

81 Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010 Bloch S.B. 2012 176 17.6 30 23

82 Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease Bernstein P. 2016 175 29.17 158 10

83 Abundant lipid and protein components of drusen Wang L. 2010 175 14.58 0 0

84 Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab Bakall B. 2013 174 19.33 24 0

85 Lutein: more than just a filter for blue light Kijlstra A. 2012 174 17.4 12 9

86 Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography Manjunath V. 2011 174 15.82 1 1

87 Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Rosenfeld P.J. 2011 174 15.82 0 0

88 Mechanisms of age-related macular degeneration and therapeutic opportunities Campagne M.L. 2014 171 21.38 611 2

89 Blood-retinal barrier Cunha-Vaz J. 2011 169 15.36 9 0

90 The prevalence of age-related eye diseases and visual Impairment in aging: current estimates Klein R. 2013 168 18.67 4 1

91 The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections Tufail A. 2014 167 20.88 7 2

92 Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration da Cruz L. 2018 166 41.5 1420 523

93 Age-related retinopathy in NRF2-deficient mice Zhao Z. 2011 166 15.09 4 1

94 Parallel findings in age-related macular degeneration and Alzheimer's disease Ohno-Matsui K. 2011 164 14.91 6 0

95 Stem cells in retinal regeneration: past. present and future Ramsden C.M. 2013 162 18 30 16

96 Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the gefal noninferiority randomized trial Kodjikian L. 2013 158 17.56 26 3

97 Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice Lambert V. 2013 158 17.56 6 0

98 Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis Rudnicka A.R. 2012 157 15.7 1 1

99 Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration Ho A.C. 2014 156 19.5 20 2

100 Ultrahigh-speed swept-source OCT angiography in exudative AMD Moult E. 2014 156 19.5 4 2

TCN: total citation number; ACpY: average citation per year; AAS: altmetric attention score; NTs: number of tweets.

Table 2

Journals of the Top-100 cited articles according to the number of articles

Journal name Number of articles IF* Q category** H Index**

Ophthalmology 27 8 1 229

Progress In Retinal And Eye Research 7 15 1 141

British Journal Of Ophthalmology 6 4 1 146

American Journal Of Ophthalmology 5 4 1 179

Lancet 5 60 1 747

Nature Genetics 4 28 1 550

Proceedings Of The National Academy Of Sciences Of The United States Of America 4 9 1 737

Molecular Aspects Of Medicine 3 10 1 128

Retina-The Journal Of Retinal And Vitreous Diseases 3 3 1 105

Jama Ophthalmology (Formerly Known As Archives Of Ophthalmology) 3 6 1 190

Autophagy 2 10 1 135

Cell 2 39 1 747

Investigative Ophthalmology & Visual Science 2 1 1 209

Jama-Journal Of The American Medical Association 2 46 1 654

Lancet Global Health 2 22 1 72

New England Journal Of Medicine 2 75 1 987

Plos One 2 3 1 300

Annual Review Of Genomics And Human Genetics 1 7 1 112

Biomedical Optics Express 1 4 1 76

Bmc Ophthalmology 1 1 2 39

Cellular And Molecular Life Sciences 1 6 1 210

Cochrane Database Of Systematic Reviews 1 8 1 261

Development 1 6 1 315

European Journal Of Ophthalmology 1 2 2 51

Graefes Archive For Clinical And Experimental Ophthalmology 1 2 1 96

Human Molecular Genetics 1 5 1 269

Journal Of Pathology 1 6 1 176

Nature 1 43 1 1159

Nature Biotechnology 1 37 1 426

Nature Medicine 1 36 1 524

Nature Protocols 1 10 1 230

Nature Reviews Immunology 1 40 1 371

Neuron 1 14 1 453

Nutrients 1 1 1 93

Ophthalmic Surgery Lasers & Imaging Retina 1 1 2 55

Stem Cell Reports 1 6 1 65

IF: Impact Factor

*: 2019 Clarivate Journal Citation Reports **: 2020 Scimago Journal and Country Rank

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

Table 3

Comparison of AAS and TCN of the Top-100 cited articles according to the study types

Study Type-Subtype Article Number Level of Evidence** AAS, median (IQR) p* TCN, median (IQR) p*

Original Scientific Paper 72

Prospective Randomized Clinical Trial 20 1 20 (8-49) 254 (180-522)

Meta-analysis 9

Systematic Review 1

Experimental Animal and/or Post-mortem Study 9 2 13 (4-89) 212 (174-469)

Prospective Cohort Study 3

Prospective Comparative Study 10 0.278 0.549

Retrospective Comparative Study 5

Prospective Descriptive Study 3 3 8 (2-19) 220,5 (191-290)

Retrospective Descriptive Study 3

Cross-Sectional Study 2

Case Series 7

Guideline and Advisory Documents 1 4 12 (6-30,5) 206,5 (176,5-291)

Review 25

Review-Seminar 2

AAS: altmetric attention score; TCN: total citation number

*Kruskal-Wallis Test; p<0.05 significant

**Scottish Intercollegiate Guidelines Network (SIGN)

Table 4

Comparison of TCN and AAS of the Top-100 cited articles based on main topic categories

Main topic Number of articles TCN, median (IQR) AAS, median (IQR)

The whole article 100 221 (178-380,75) 13 (4-37,75)

Treatment 34 225 (179-577) 18 (8-97)

Anti-VEGF injection 25

Treatment outcome; efficacy and safety 4

Treatment regimens and outcome; efficacy, safety 15

Treatment outcome and prognostic features 3

Switch protocol and treatment outcome 2

Pharmacokinetics and systemic exposure 1

Drug implant 1

Retinal stem cell transplantation 6

Dietary Supplements 2

Diagnosis and image analyses 13 211 (189-381) 4(3-13)

Medical image analyses 10

OCT 4

OCT-angiography 3

OCT, FFA, FAF, fundus photo 3

Artificial intelligence analyses 3

OCT 2

Fundus photo 1

Pathophysiology 12 233 (186,5-368) 7,5 (3,5-13,5)

Immunological process 1

Immunological and inflammatory process 4

Oxidative stress 2

Oxidative stress and inflammatory process 2

Oxidative stress and immunological process 1

Oxidative stress, inflammatory and immunological process 2

Pathophysiology and genetics 12 280,5 (205,5-377) 26,5 (15,5-38)

Epidemiology 10 210 (176-321) 13 (1-30)

Histopathology 6 189 (164-218) 4,5 (0-6)

Molecular mechanisms of antioxidant molecules 3 175 (174-176) 158 (12-189)

Pathophysiology and treatment 3 177 (171-899) 56 (50-611)

Classification and staging 2 400 (230-570) 37,5 (1-74)

Prognostic features 2 345,5 (311-380) 3,5 (3-4)

Pathophysiology, diagnosis and image analyses 1 169 (169-169) 9 (9-9)

Histopathology and molecular mechanisms 1 178 (178-178) 6 (6-6)

Diagnosis and therapeutic management 1 219 (219-219) 124 (124-124)

TCN: total citation number, AAS: altmetric attention score, VEGF: vascular endothelial growth factor, OCT: optic coherence tomography, FFA: fundus fluorescein angiography, FAF: fundus autofloresans.

Table 5

Correlation analysis

TCN ACpY NTs IF H-index Q category

AAS r p 0.162 0.107 0.382** 0.001 0.779** 0.001 0.394** 0.001 0.238* 0.017 -0.066 0.512

TCN r p 1 0.889** 0.001 0.131 0.195 0.516** 0.001 0.403** 0.001 -0.060 0.552

ACpY r 1 0.373** 0.602** 0.389** -0.086

p 0.001 0.001 0.001 0.394

NTs r p 1 0.497** 0.001 0.351** 0.001 -0.055 0.585

IF r p 1 0.801** 0.001 -0.141 0.162

H-index r p 1 -0.185 0.065

AAS: altmetric attention score; TCN: total citation number; ACpY: average citation per year; NTs: number of tweets; IF: journal impact factor. Impact factor: 2019 Clarivate Journal Citation Reports; H index: 2020 Scimago Journal and Country Rank. **Correlation is significant at the 0.01 level *Correlation is significant at the 0.05 level

r was obtained from Spearman rank or Pearson correlation coefficient.

was published in 2011 with a TCN of 1667 [14]. There were only eight articles in the T100 list that did not have AAS yet. The article with the highest AAS with 1420 in the T100 list was Cruz L et al's article, which was entitled as "Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration", and it was published in 2018 [15]. Also this article had the highest NTs in accordance with the highest AAS.

Twitter analysis

It was discovered that 68 articles of the T100 list were shared on Twitter. Five of the top-10 articles with the highest NTs dealt with stem cell treatment in AMD; two of them dealt with diagnostic image analyses using artificial intelligence techniques.

Journal perspective

The journal of Ophthalmology published most articles, with 27, among the T100 list's 36 journals (Table 2). The most cited article was from New England Journal of Medicine, which had the greatest IF among T100 journals. The second most cited article was from the journal of Lancet Global Health. The article with the highest AAS was published in the journal of Nature Biotechnology. According to SJCR, all journals received Q1 scores, with the exception of three journals which received Q2 scores.

Article types

According to SIGN, 72 articles of the T100 list represented original scientific research (Table 3). When all publications were categorized by their degree of evidence, there was no statistically significant difference in the median AAS of the four groups. (p=0.278). Similarly, there was no significant difference in the median TCN across the four groups (p=0.549). The level of evidence had no significant effect on the AAS and TCN of the articles, according to these results.

Research subjects

The bulk of publications on the T100 list were about treatment (n=34), followed by diagnosis and image analysis (n=13), pathophysiology (n=12), and pathophysiology and genetics (n=12) (Table 4). But the main subject with the greatest median AAS was molecular mechanisms of antioxidant molecules, with a value of 158 (12-189). The main subject with the greatest median TCN was classification and staging, with a value of 400 (230-570).

Correlation analysis

The correlation analysis findings are shown in Table 5 and Figure 2. While AAS and NTs did not have a significant correlation with TCN (r values were 0.162 and 0.131, p values were 0.107 and 0.195, respectively), they did show a weak positive correlation with ACpY (r values were 0.382 and 0.373, p values were 0.001 and 0.001, respectively). Notably, AAS had a weak positive correlation with journal IF, but NTs had a moderate positive correlation with journal IF (r values were 0.394 and 0.497, p values were 0.001 and 0.001, respectively). Additionally, both AAS and NTs showed weak positive correlation with H-index (r values were 0.238 and 0.351, p values were 0.017 and 0.001, respectively). It is worth noting that, although NTs did not correlate with TCN, they did have a moderate positive linkage with journal IF.

Visualization analysis

The total strength of bibliographic coupling relationships with other nations was estimated and presented for each of the 37 countries in the T100 list (Figure 3A). Countries with large nodes are more efficient and productive. The thickness and distance of links between nodes represent the level of communication and cooperation among countries. The United States was the most productive and impressive country regarding the total amount of documents (76 documents), TCN received (26758 citations), and international cooperation (24677 link strength).

Figure 2-Scatter plot of relationship between Altmetric Attention Score (AAS) and Number of tweets (Figure 2A), relationship between AAS and total citation number (Figure 2B) Figure 2A: There was strong positive correlation between Altmetric Attention Score and Number of Tweet (r=0.779; p=0.001). According to univariate linear regression analysis ~61% of variation in Altmetric Attention Score was explained by Number of Tweet. 1 unit increase in Tweet resulted in 2.36 increase in Altmetric Attention Score model to estimate Altmetric Attention Score was YAltmetric Attention Score = 31.40+2.36*X Number of Tweet Figure 2B: There was weak positive correlation between Altmetric Attention Score and Average citation pear year cite (r=0.382; p=0.001). According to univariate linear regression analysis ~15% of variation in Altmetric Attention Score was explained by Average citation pear year cite. 1 unit increase in Average citation pear year cite resulted in 2.51 increase in Altmetric Attention Score model to estimate Altmetric Attention Score was YAltmetric Attention Score = -10.54+2.51*X Average per Year Citation

0 -- 10 SO EÜ 100 120 110 160 1 ED M0 ■;£[, ;c0 330 300 330 100 130 300

Number of Tweet Total Citations

Figure 3-Network visualization maps of age related macular degeneration research The strength of bibliographic country coupling linkages is displayed in Figure 3A. The co-occurrence analysis of high-frequency keywords is displayed in Figure 3B.

The United States was followed by England, Germany, Australia, France, Japan, Singapore, Netherlands, South Korea, and North Ireland, respectively TCN of top-10 countries were 26758, 7882, 7549, 5360, 4379, 4214, 4903, 3001, 2762, and 3098, respectively.

The hotspots of AMD research were discovered with a cooccurrence analysis of frequently used keywords. The minimal number of keyword co-occurrences criteria was chosen to be 2.The criteria was met by 21 of the 129 retrieved keywords related to AMD. The system was used to cluster relevant keywords, and the five major clusters were represented by the colors red, green, blue, yellow, and purple, respectively (Figure 3B). The most prevalent keywords were "age-related macular degeneration" and "oxidative stress".

Discussion

We compared bibliometric analyses to altmetric analyses of the highly cited articles in the field of AMD research in the current study. While there was no relationship between AAS and TCN, a significant correlation between AAS and ACpY was discovered. Additionally, we found a significant correlation between AAS and journal IF and H-index. We noticed that the majority of the highly cited articles in the field of AMD research in the last decade have mainly focused on AMD treatment, especially anti-vascular endothelial growth factor (anti-VEGF) therapy.

While traditional bibliometric analyses are useful for assessing the impact value of scientific articles, they have significant disadvantages. A specific amount of time must pass before the measurement of citation metrics of the published article. Therefore it is not possible to evaluate the impact of a recently published article by bibliometric analysis in its earliest years. It causes difficulty for researchers to find impressive articles, keep track of fresh study subjects, and come up with new research areas. Additionally, the reason of citing the articles is unclear. The possibility of referring highly cited articles is usually raised [6]. Furthermore, citation quantities may be influenced unfairly because of self-citation or citation of relevant authors' articles. Therefore a new technique to quickly evaluate the quality and impact value of articles is needed. This is the first research that we are aware of that evaluated articles with both bibliometric and altmetric analysis in the field of AMD research. While AAS and NTs had no significant correlation with TCN (r values of 0,162 and 0,132, respectively), they did have weak

positive correlation with ACpY (r values of 0,382 and 0,373, respectively). This indicates that articles which have been cited regularly over the years and remain actual are more valuable on social media and Twitter. NTs can be used as a valuable indicator for predicting the early period impact values of articles.

While AAS and NTs did not correlate with TCN, AAS did show a weak positive correlation with journal IF, and also TCN showed a moderate positive correlation with journal IF as well. This issue may be explained by the fact that AAS and NTs were positively correlated with ACpY. Journal IF is influenced by citations received in recent years. Articles which continue to be debated receive a greater amount of attention on Twitter. Another explanation could be that journals which have had their own Twitter accounts for a long time have more followers. As the number of social media followers increases, the awareness of the journals and accessing their articles also increase. It was revealed that tweeting about recently published articles increases the number of citations in following years [16-18]. It was found that medical journals with Twitter profiles have greater IF, and that there is a positive association between journal IF and the amount of Twitter account followers [19-21].

Kolahi et al. discovered a statistically significant positive correlation between AAS and TCN in their study [22]. He added that the intensity of this association will rise in the future due to the growth of social media. Gargovich et al. found an increasing positive correlation between AAS and TCN in their altmetric study in the field of pediatric dentistry investigation between 2014 and 2017 [23]. Suzan et al. also revealed a statistically significant positive correlation between AAS and TCN, ACpY, journal IF, and H-index in their altmetric study on malnutrition research [24]. However, Haustein et al. discovered relatively weak correlation between NTs and TCN [25]. Thelwall, a social media analyst with more than a hundred researches on metrics, claimed that there is a negative correlation between NTs and TCN because of long duration which is needed for citation, unlike quick sharing on Twitter [26]. We found both AAS and NTs to have positive correlation with ACpY, journal IF, and H-index. These findings reveal that altmetric and bibliometric parameters are generally compatible and correlated with each other. In accordance with Thelwall, AAS and NTs were not correlated with TCN in our study. We discovered that ACpY is a more important indication than TCN for AAS and NTs. Social media users pay more attention to the articles which continue to be discussed and are current. In addition to this, articles with

older publication years usually have higher TCN because of the accumulation of citations. Due to the fact that social media usage was not widespread in the early years of the last decade, AAS of articles with older publication years may be low. This could also explain why there was no significant association between AAS and TCN in our study.

Seventy two articles of the T100 list articles were original scientific research. Twenty of these articles were randomized clinical trials, and ten of these articles were meta-analyses and systematic reviews with a level of evidence of 1 according to SIGN criteria. Suzan et al. discovered a statistically significant differences between TCN but no statistically significant differences between AAS in terms of study types [24]. We found that the level of evidence did not make a significant difference in TCN and AAS when we classified and compared the articles according to the study types and level of evidence. However, it was notable that both articles with highest TCN and AAS were randomized clinical trials with a level of evidence 1.

iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.

It is important to classify the T100 list according to the main subject areas in order to determine which subjects get far more interest from scholars and social media users. The main topics of the articles with the highest TCN median value were classification and staging (400) and prognostic features (345.5). The main topics of the articles with the highest AAS median value were molecular mechanisms of antioxidant molecules (158) and diagnostic and therapeutic management (124). According to the main topic analysis of T100 list, we found out that majority of articles were about treatment, particularly anti-VEGF therapy. In accordance with this, Martin et al.'s article entitled as "Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group" received the highest TCN [14]. However, the article entitled as "Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration" by Cruz et al. had both the greatest AAS and NTs in the T100 list [15]. The academic community made the highest citations to the article which is evaluating the treatment protocols, efficacy, and safety of anti-VEGF therapies, which are currently used to treat AMD. On the other hand, anti-VEGF medications are a kind of medication that reduces and suppresses the progression of neovascular AMD but cannot provide a complete cure in advanced AMD. Social media users were most interested in the article about embryonic stem cell therapy, which had the potential to be a more dramatic therapeutic option for AMD than symptomatic anti-VEGF medications. The top ten articles with the highest AAS had the following topics: embryonic stem cell treatment (n—4), anti-VEGF treatment (n—2), diagnostic image analysis using artificial intelligence techniques (n—2), dietary supplement treatment (n—1), and epidemiology (n—1). It was remarkable that social media users showed great interest in newly developed techniques such as embryonic stem cell therapy and artificial intelligence. It was notable that six of the ten articles with the highest AAS were produced in the United States, which was also the most productive country according to the bibliometric visualization analysis.

As a consequence of increasing use of Twitter for professional reasons, scholars and clinicians have begun to frequently utilize Twitter for academic knowledge transfer in recent years. Twitter dismantles academic hierarchy and enables scientists and clinicians from across the globe to interact and debate research topics. According to the report, 71.9 percent of 160 ophthalmologists use social media in 2020 [27]. Additionally, Alfaris et al. reported that 35 percent of medical students use

Twitter for vocational training in their study on the effect of social media use on academic achievement in medical students [28]. Numerous medical journals also have their own Twitter accounts. Over 20% of all published articles are announced at least once on Twitter [29]. In our study, 68 articles in the T100 list were shared on Twitter. It is worth noting that the journals of Nature Biotechnology, Jama-Journal Of The American Medical Association, New England Journal Of Medicine, Cell, And Lancet, which published the first five articles with the highest AAS in the T100 list, have their own Twitter accounts. Furthermore, journal of Ophthalmology, which has the most number of articles in the T100 list with 27 articles, also has a Twitter account. On the other hand, it is noteworthy to see that the journals which published the first and second articles with highest TCN (New England Journal of Medicine and Lancet Global Health, respectively) and the journal which published the article with the highest AAS (Nature Biotechnology) were general medicine journals which were not specialized in ophthalmology field.

The limitation of our study is that we used NTs in our altmetric analysis, but we did not define detailed Twitter demographics. The amount of Twitter followers might be used to estimate the amount of individuals contacted and the spread of the content. It might be useful to evaluate the occupations, ages, genders, and geographical regions of Twitter users to determine the hot topics for different target groups. Further altmetric researches are needed to conduct detailed Twitter analyses, involving user classifications, amount of followers, and geography.

Conclusion

This study carried out both detailed altmetric and bibliometric analyses in the field of AMD research. AAS and NTs had significant positive correlation with ACpY, journal IF, and H-index. Therefore, altmetric analysis was found to be a useful option for rapid assessment of the impact of articles whose citation analysis period has not yet completed. Furthermore, AAS and NTs had a significant positive correlation with ACpY, implying that social media users are more interested in articles that continue to be cited over time and remain actual. Additionally, it is worth noting that NTs have a greater impact on journal IF than AAS. The majority of the mostly cited articles in the field of AMD research were about treatment, especially anti-VEGF medication. However social media users paid more attention to embryonic stem cell therapy as a treatment option for AMD. Performing altmetric analyses in the evaluation of articles, in addition to the bibliometric analyses, offers scholars a wealth of information about trending topics in AMD research.

Disclosures: There is no conflict of interest for all authors.

Acknowledgements: None.

Funding: None.

References

1. Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, Jong PT. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42(10):2237-2241.

2. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572. https://doi.org/10.1001/archopht.1941.00870100042005

3. Cooper ID. Bibliometrics basics. J MedLibrAssoc. 2015;103(4):217-218. https://doi.org/10.3163/1536-5050.103A013

4. Zou X, Yue WL, Vu HL. Visualization and analysis of mapping knowledge domain of road safety studies. Accid Anal Prev. 2018;118(9):131-145. https://doi.org/10.1016/j.aap.2018.06.010

5. Zhang XD, Wang CX, Jiang HH, Jing SL, Zhao JY, Yu ZY. Trends in research related to high myopia from 2010 to 2019: a bibliometric and knowledge mapping analysis. Int J Ophthalmol. 2021;14(4):589-599. https://doi.org/10.18240/ijo.2021.04.17

6. Citrome L. Moving forward with article level metrics: introducing altmetrics. Int J Clin Pract. 2015;69(8):811. https://doi.org/10.1111/ ijcp.12706

7. Gasparyan AY, Yessirkepov M, Voronov A, Maksaev A, Kitas G. Article-Level Metrics. J Korean Med Sci. 2021;36(11):e74. https:// doi.org/10.3346/jkms.2021.36.e74

8. Melero R. Altmetrics - a complement to conventional metrics. Biochem Med. 2015;25(2):152-160. https://doi.org/10.11613/BM.2015.016

9. Bulut E, Celebi ARC, Dokur M, Dayi O. Analysis of trending topics in glaucoma articles from an altmetric perspective. Int Ophthalmol. 2021;41(6):2125-2137. https://doi.org/10.1007/s10792-021-01770-9

10. Men M, Fung SSM, Tsui E. What's trending: a review of social media in ophthalmology. Curr Opin Ophthalmol. 2021;32(4):324-330. https://doi.org/10.1097/ICU.0000000000000772

11. Scottish Intercollegiate Guidelines Network (SIGN 50). In: a guideline developer's handbook: Healthcare Improvement Scotland. Available from: http://www.sign.ac.uk/assets/. Accessed 3 April 2021.

12. Paladugu R, Schein M, Gardezi S, Wise L. One hundred citation classics in general surgical journals. World J Surg. 2002;26(9):1099-1105. https://doi.org/10.1007/s00268-002-6376-7

13. Frapporti G, Linnartz LAM, Vriend SP. SPEARMEN-a dBase program for computation and testing of Spearman rank correlation coefficient distributions. Comput and Geosci. 1991;17(4):569-589. https://doi.org/10.1016/0098-3004(91)90115-T

14. Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364 (20):1897-1908. https://doi.org/10.1056/NEJMoa1102673

15. da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018;36(4):328-337. https://doi.org/10.1038/nbt.4114

16. Hayon S, Tripathi H, Stormont IM, Dunne MM, Naslund MJ, Siddiqui MM.Twitter Mentions and Academic Citations in the Urologic Literature. J Urol. 2019;123(6):28-33. https://doi.org/10.1016/j.urology.2018.08.041

17. Paradis N, Knoll MA, Shah C, Lambert C, Delouya G, Bahig H, et al. Twitter: A Platform for Dissemination and Discussion of Scientific Papers in Radiation Oncology. Am J Clin Oncol. 2020;43(6):442-445. https://doi.org/10.1097/COC.0000000000000685

18. Smith ZL, Chiang AL, Bowman D, Wallace MB. Longitudinal relationship between social media activity and article citations in the journal Gastrointestinal Endoscopy. GastrointestEndosc. 2019;90(1):77-83. https://doi.org/10.1016/j.gie.2019.03.028

19. Hughes H, Hughes A, Murphy C. The Use of Twitter by the Trauma and Orthopaedic Surgery Journals: Twitter Activity, Impact Factor, and Alternative Metrics. Cureus. 2011;9(12):e1931.

20. Kelly BS, Redmond CE, Nason GJ, Healy GM, Horgan NA, Heffernan EJ. The Use of Twitter by Radiology Journals: An Analysis of Twitter Activity and Impact Factor. J Am Coll Radiol. 2016;13(11):1391-1396. https://doi.org/10.1016/jjacr.2016.06.041

21. Duffy CC, Bass GA, Linton KN, Honan DM. Social media and anaesthesia journals. Br J Anaesth. 2015;115(6):940-941. https://doi. org/10.1093/bja/aev389

22. Kolahi J, Khazaei S, Iranmanesh P, Kim J, Bang H, Khademi A. Meta-Analysis of Correlations between Altmetric Attention Score and Citations in Health Sciences. Biomed Res Int. 2021;6680764. https://doi.org/10.1155/2021/6680764

23. Garcovich D, Adobes Martin M. Measuring the social impact of research in Paediatric Dentistry: An Altmetric study. Int J Paediatr Dent. 2020;30(1):66-74. https://doi.org/10.1111/ipd.12575

24. Suzan V, Unal D. Comparison of attention for malnutrition research on social media versus academia: Altmetric score analysis. Nutr J. 2021;82:111060. https://doi.org/10.1016/j.nut.2020.111060

25. Haustein S, Peters I, Bar-Ilan J, Priem J, Shema H, Terliesner J. Coverage and adoption of altmetrics sources in the bibliometric community. Scientometrics. 2014;101(2):1145-1163. https://doi.org/10.1007/s11192-013-1221-3

26. Thelwall M, Fairclough R. The influence of time and discipline on the magnitude of correlations between citation counts and quality scores. Journal of Informetrics. 2015;9(3):529-541.https://doi.org/10.1016/j.joi.2015.05.006

27. Al-Khersan H, Lazzarini TA, Fan KC, Patel NA, Tran AQ, Tooley AA, et al. Social media in ophthalmology: An analysis of use in the professional sphere. Health Informatics J. 2020;26(4):2967-2975. https://doi.org/10.1177/1460458220954610

28. AlFaris E, Irfan F, Ponnamperuma G, Jamal A, Van der Vleuten C, Al Maflehi N. The pattern of social media use and its association with academic performance among medical students. Med Teach. 2018;40(1):77-82. https://doi.org/10.1080/0142159X.2018.1465536

29. Haustein S, Costas R, Lariviére V. Characterizing social media metrics of scholarly papers: the effect of document properties and collaboration patterns. PLoS One. 2015;10(3):e0120495. https://doi.org/10.1371/journal.pone.0120495

i Надоели баннеры? Вы всегда можете отключить рекламу.